Anna Libera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anna Libera has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Damian Zienkiewicz
Szpital Praski pw. Przemienia Pańskiego, Solidarności 67, 03-401 Warsaw, Poland
9 shared publications - Gabriela Makulec
Wojskowy Instytut Medyczny, Szaserów 128, 04-141 Warsaw, Poland
9 shared publications - Julia Maria Kostro
Stefan Żeromski Specialist Hospital, Osiedle na Skarpie 66, 31-913 Kraków, Poland
9 shared publications - Karolina Bartkiewicz
Medical University of Warsaw (WUM), 61 Żwirki i Wigury Street, 02-091 Warsaw, Poland
9 shared publications - Karolina Domosud
Wojskowy Instytut Medyczny, Szaserów 128, 04-141 Warsaw, Poland
9 shared publications - Lizaveta Novik
Medical University of Warsaw (WUM), 61 Żwirki i Wigury Street, 02-091 Warsaw, Poland
9 shared publications
Latest Publications
- Open Access
- 22 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 70
Risk Factors for Sudden Infant Death Syndrome: An Updated Narrative Review
Background: Sudden Infant Death Syndrome (SIDS) is defined as the sudden and unexplained death of an infant younger than one year of age that remains unexplained after a comprehensive investigation, including autopsy, examination of the death scene, and review of clinical and family history. Despite a substantial reduction in incidence following the implementation of safe sleep recommendations, SIDS remains an important public health concern. Multiple maternal, infant-related, environmental, and socioeconomic factors contribute to SIDS risk. Objective: The aim of this narrative review was to summarize current evidence regarding modifiable and non-modifiable risk factors associated with Sudden Infant Death Syndrome and to discuss evidence-based preventive strategies. Methods: A narrative review of literature from PubMed/MEDLINE, Scopus, Web of Science, and Embase was conducted, including reviews, meta-analyses, observational studies, and clinical guidelines. Results: Current evidence indicates that SIDS is a multifactorial condition resulting from interactions between intrinsic infant vulnerability, developmental factors, and external environmental stressors. The strongest modifiable risk factors include prenatal and postnatal tobacco exposure, prone sleeping position, unsafe sleep environments, overheating, and bed-sharing in high-risk circumstances. Prematurity, low birth weight, male sex, and genetic susceptibility contribute to biological vulnerability. Breastfeeding and pacifier use during sleep are associated with reduced SIDS risk. Conclusions: SIDS prevention requires a multifactorial approach focused on reducing modifiable environmental risks, promoting safe sleep practices, eliminating tobacco exposure, and improving parental education. Further research is needed to better understand genetic and biological mechanisms contributing to individual susceptibility.
- 22 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 70
Open AccessRisk Factors for Sudden Infant Death Syndrome: An Updated Narrative Review
Background: Sudden Infant Death Syndrome (SIDS) is defined as the sudden and unexplained death of an infant younger than one year of age that remains unexplained after a comprehensive investigation, including autopsy, examination of the death scene, and review of clinical and family history. Despite a substantial reduction in incidence following the implementation of safe sleep recommendations, SIDS remains an important public health concern. Multiple maternal, infant-related, environmental, and socioeconomic factors contribute to SIDS risk. Objective: The aim of this narrative review was to summarize current evidence regarding modifiable and non-modifiable risk factors associated with Sudden Infant Death Syndrome and to discuss evidence-based preventive strategies. Methods: A narrative review of literature from PubMed/MEDLINE, Scopus, Web of Science, and Embase was conducted, including reviews, meta-analyses, observational studies, and clinical guidelines. Results: Current evidence indicates that SIDS is a multifactorial condition resulting from interactions between intrinsic infant vulnerability, developmental factors, and external environmental stressors. The strongest modifiable risk factors include prenatal and postnatal tobacco exposure, prone sleeping position, unsafe sleep environments, overheating, and bed-sharing in high-risk circumstances. Prematurity, low birth weight, male sex, and genetic susceptibility contribute to biological vulnerability. Breastfeeding and pacifier use during sleep are associated with reduced SIDS risk. Conclusions: SIDS prevention requires a multifactorial approach focused on reducing modifiable environmental risks, promoting safe sleep practices, eliminating tobacco exposure, and improving parental education. Further research is needed to better understand genetic and biological mechanisms contributing to individual susceptibility.
- Open Access
- 16 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
THE ROLE OF NUTRITIONAL INTERVENTIONS AND SUPPLEMENTATION IN CHRONIC KIDNEY DISEASE – A NARRATIVE REVIEW
Background: Chronic kidney disease (CKD) affects approximately 10% of the population and is associated with increased cardiovascular risk and mortality. In advanced stages, protein-energy wasting (PEW) and malnutrition-inflammation complex syndrome (MICS) are common and worsen clinical outcomes. Evidence suggests that nutritional interventions, including modification of protein, sodium, potassium, and phosphorus intake, and selected supplementation, may slow CKD progression and reduce metabolic complications. Aim: This review summarizes current evidence on nutritional interventions and supplementation in CKD, considering disease stage and treatment modality, and identifies gaps requiring further research. Materials and methods: A narrative review of international guidelines (KDIGO, KDOQI, ESPEN) and clinical trials and meta-analyses published between 2009-2026, identified through searches of PubMed, Cochrane Library, Scopus, and Google Scholar, focusing on CKD stages G3-G5. Results: Individualized protein restriction, sodium limitation, and qualitative phosphorus control improve metabolic parameters, blood pressure and albuminuria. Low- and very low-protein diets, particularly with amino acid ketoanalogue supplementation, are associated with slower CKD progression and a delayed initiation of renal replacement therapy. Plant-based diets may additionally improve acid-base balance, phosphate metabolism, and inflammation. The strongest evidence for supplementation concerns vitamin D, iron, and amino acid ketoanalogues, while data on omega-3 fatty acids, probiotics, and B vitamins remain inconclusive. Conclusions: Nutritional management is a key component of CKD care. Individualized dietary strategies and targeted supplementation may provide nephroprotective and metabolic benefits, although further high-quality randomized trials are needed to confirm effects on hard clinical endpoints.
- 16 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
Open AccessTHE ROLE OF NUTRITIONAL INTERVENTIONS AND SUPPLEMENTATION IN CHRONIC KIDNEY DISEASE – A NARRATIVE REVIEW
Background: Chronic kidney disease (CKD) affects approximately 10% of the population and is associated with increased cardiovascular risk and mortality. In advanced stages, protein-energy wasting (PEW) and malnutrition-inflammation complex syndrome (MICS) are common and worsen clinical outcomes. Evidence suggests that nutritional interventions, including modification of protein, sodium, potassium, and phosphorus intake, and selected supplementation, may slow CKD progression and reduce metabolic complications. Aim: This review summarizes current evidence on nutritional interventions and supplementation in CKD, considering disease stage and treatment modality, and identifies gaps requiring further research. Materials and methods: A narrative review of international guidelines (KDIGO, KDOQI, ESPEN) and clinical trials and meta-analyses published between 2009-2026, identified through searches of PubMed, Cochrane Library, Scopus, and Google Scholar, focusing on CKD stages G3-G5. Results: Individualized protein restriction, sodium limitation, and qualitative phosphorus control improve metabolic parameters, blood pressure and albuminuria. Low- and very low-protein diets, particularly with amino acid ketoanalogue supplementation, are associated with slower CKD progression and a delayed initiation of renal replacement therapy. Plant-based diets may additionally improve acid-base balance, phosphate metabolism, and inflammation. The strongest evidence for supplementation concerns vitamin D, iron, and amino acid ketoanalogues, while data on omega-3 fatty acids, probiotics, and B vitamins remain inconclusive. Conclusions: Nutritional management is a key component of CKD care. Individualized dietary strategies and targeted supplementation may provide nephroprotective and metabolic benefits, although further high-quality randomized trials are needed to confirm effects on hard clinical endpoints.
- Open Access
- 14 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 58
Premature Hair Graying: Underlying Contributors and Management Approaches - An Updated Literature Review
Background: Premature hair graying (PHG) is considered a distinct clinical entity, in which the presence of grey hairs on the scalp appears at a young age, generally before 20 years of age in individuals of European descent or slightly later, before 30 years of age in individuals of African ancestry. The etiology of premature hair graying remains multifactorial. Aim of the study: The objective of this narrative review was to summarize the potential contributors, which may play a role in graying of the hair at the young age. Material and methods: This comprehensive narrative literature review was conducted based on the scientific literature retrieved from the PubMed database. The analysis included original studies and case reports, which had been concentrated on the occurrence of PHG. Results: The available literature suggests correlations between premature canities and nutrient deficiencies in cobalamin, copper, folic acid, biotin, iron, calcium, zinc, cholecalciferol. The positive association with PHG indicate also high level of oxidative stress, long-term emotional stress, tobacco smoking, genetic disorders, autoimmune diseases or just be a side effect of some medications. Conclusions: The etiology of PHG is multifactorial. To date no effective therapeutic method capable of reversing premature hair graying has been established, highlighting the need for further research.
- 14 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 58
Open AccessPremature Hair Graying: Underlying Contributors and Management Approaches - An Updated Literature Review
Background: Premature hair graying (PHG) is considered a distinct clinical entity, in which the presence of grey hairs on the scalp appears at a young age, generally before 20 years of age in individuals of European descent or slightly later, before 30 years of age in individuals of African ancestry. The etiology of premature hair graying remains multifactorial. Aim of the study: The objective of this narrative review was to summarize the potential contributors, which may play a role in graying of the hair at the young age. Material and methods: This comprehensive narrative literature review was conducted based on the scientific literature retrieved from the PubMed database. The analysis included original studies and case reports, which had been concentrated on the occurrence of PHG. Results: The available literature suggests correlations between premature canities and nutrient deficiencies in cobalamin, copper, folic acid, biotin, iron, calcium, zinc, cholecalciferol. The positive association with PHG indicate also high level of oxidative stress, long-term emotional stress, tobacco smoking, genetic disorders, autoimmune diseases or just be a side effect of some medications. Conclusions: The etiology of PHG is multifactorial. To date no effective therapeutic method capable of reversing premature hair graying has been established, highlighting the need for further research.
- Open Access
- 30 April 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
VAGINAL MICROBIOME ALTERATIONS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME
Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine disorders in the population of reproductive-age women. Although there is considerable research on gut dysbiosis in PCOS, alterations in the vaginal microbiome are comparatively understudied, despite their possible reproductive implications. The main aim of this review was to summarize current evidence regarding vaginal microbiome composition in women with PCOS and evaluate its associations with relevant clinical parameters. A literature search was performed using PubMed for studies published between January 2015 and November 2025. Eight studies met the inclusion criteria, each examining vaginal microbiome composition in women with PCOS. The most important findings included reduced Lactobacillus dominance, increased alpha-diversity, and enrichment of anaerobic taxa, such as Gardnerella vaginalis, Prevotella, and Ureaplasma species. Current evidence indicates that vaginal dysbiosis is more common among women with PCOS than in healthy controls, though it is not universal. Causal relationships in this field remain unclear, and data on interventions are insufficient. Randomized controlled trials evaluating interventions that target the microbiome and their impact on reproductive outcomes are an important research priority.
- 30 April 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
Open AccessVAGINAL MICROBIOME ALTERATIONS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME
Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine disorders in the population of reproductive-age women. Although there is considerable research on gut dysbiosis in PCOS, alterations in the vaginal microbiome are comparatively understudied, despite their possible reproductive implications. The main aim of this review was to summarize current evidence regarding vaginal microbiome composition in women with PCOS and evaluate its associations with relevant clinical parameters. A literature search was performed using PubMed for studies published between January 2015 and November 2025. Eight studies met the inclusion criteria, each examining vaginal microbiome composition in women with PCOS. The most important findings included reduced Lactobacillus dominance, increased alpha-diversity, and enrichment of anaerobic taxa, such as Gardnerella vaginalis, Prevotella, and Ureaplasma species. Current evidence indicates that vaginal dysbiosis is more common among women with PCOS than in healthy controls, though it is not universal. Causal relationships in this field remain unclear, and data on interventions are insufficient. Randomized controlled trials evaluating interventions that target the microbiome and their impact on reproductive outcomes are an important research priority.
- Open Access
- 25 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 54
Metformin as a New Therapeutic Option for Endometriosis: Promise, Limits and Future Directions
Endometriosis is a chronic, estrogent-dependent, inflammatory disease affecting a plethora of women of reproductive age and is a major cause of pelvis pain and subfertility. Current treatments – surgery and hormonal supression are often only partly effective, lead to further fertility issues or have substantial adverse effects, creating an unmet need for a non-hormonal, disease modyfing therapy option (Carvalho, J. C., et al; 2021). Metformin, a biguanide used worldwide as a first-line insulin-sensitizing drug for type 2 diabetes, has emerged as a therapeutic option for endometriosis because of its pleiotropic anti-inflammatory, anti-proliferative, anti-angiogenic and metabolic effects. This paper analyses mechanistic, preclinical and early clinical evidence on metformin use in endometriosis, with particular attention to how the drug interacts with the known pathophysiology of the disease (Kimber-Trojnar, Ż., et al; 2022). Rather than an immediate replacement for standard hormonal therapies, metformin currently appears best positioned as a promising adjuvant or alternative for selected patients – particularly those with co-existing metabolic dysfunction pending high-quality clinical trials (Zhang, H., et al; 2023).
- 25 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 54
Open AccessMetformin as a New Therapeutic Option for Endometriosis: Promise, Limits and Future Directions
Endometriosis is a chronic, estrogent-dependent, inflammatory disease affecting a plethora of women of reproductive age and is a major cause of pelvis pain and subfertility. Current treatments – surgery and hormonal supression are often only partly effective, lead to further fertility issues or have substantial adverse effects, creating an unmet need for a non-hormonal, disease modyfing therapy option (Carvalho, J. C., et al; 2021). Metformin, a biguanide used worldwide as a first-line insulin-sensitizing drug for type 2 diabetes, has emerged as a therapeutic option for endometriosis because of its pleiotropic anti-inflammatory, anti-proliferative, anti-angiogenic and metabolic effects. This paper analyses mechanistic, preclinical and early clinical evidence on metformin use in endometriosis, with particular attention to how the drug interacts with the known pathophysiology of the disease (Kimber-Trojnar, Ż., et al; 2022). Rather than an immediate replacement for standard hormonal therapies, metformin currently appears best positioned as a promising adjuvant or alternative for selected patients – particularly those with co-existing metabolic dysfunction pending high-quality clinical trials (Zhang, H., et al; 2023).
- Open Access
- 30 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
THE USE OF LOW HISTAMINE DIET – A REVIEW
Introduction: Histamine is a biologically active amine involved in inflammatory, immunological, neurological, and gastrointestinal processes. Impaired degradation of histamine, may lead to histamine intolerance and multisystem symptoms. The low-histamine diet is interesting strategy as a non-pharmacological recommendation for managing histamine-related disorders. Background: There are many disorders which symptoms may be associated with the level of histamine, for instance: chronic spontaneous urticaria, inflammatory bowel disease, recurrent headaches, gastrointestinal manifestations in hypermobile Ehlers–Danlos syndrome, and anaphylaxis-like reactions. Although dietary histamine restriction is frequently recommended, the consistency between online dietary advice and scientific evidence could be misleading. Methods: Scientific articles adressing the use of low-histamine diet were identified through an analysis of databases. Secondly, five publicly accessible websites identified through search phrases related to the low-histamine diet were analyzed. Afterwards, five scientific studies from literature databases were reviewed to compare publicly accessible information to recommendations in scientific articles from literature databases. Key findings: Analyzed articles suggest that impaired histamine degradation can result in multisystem symptoms, which may improve after implication dietary histamine restriction. The analysis of low-histamine diet recommendations revealed inconsistencies between internet-based information and literature from scientific databases. Conclusions: A low-histamine diet may provide clinical benefit in selected patients with histamine-related disorders. However, dietary recommendations are often inconsistent with scientific evidence. Implementation of the diet should be individualized and evidence-based. Further studies could be beneficial to establish clear and standardized dietary guidelines for histamine related conditions.
- 30 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
Open AccessTHE USE OF LOW HISTAMINE DIET – A REVIEW
Introduction: Histamine is a biologically active amine involved in inflammatory, immunological, neurological, and gastrointestinal processes. Impaired degradation of histamine, may lead to histamine intolerance and multisystem symptoms. The low-histamine diet is interesting strategy as a non-pharmacological recommendation for managing histamine-related disorders. Background: There are many disorders which symptoms may be associated with the level of histamine, for instance: chronic spontaneous urticaria, inflammatory bowel disease, recurrent headaches, gastrointestinal manifestations in hypermobile Ehlers–Danlos syndrome, and anaphylaxis-like reactions. Although dietary histamine restriction is frequently recommended, the consistency between online dietary advice and scientific evidence could be misleading. Methods: Scientific articles adressing the use of low-histamine diet were identified through an analysis of databases. Secondly, five publicly accessible websites identified through search phrases related to the low-histamine diet were analyzed. Afterwards, five scientific studies from literature databases were reviewed to compare publicly accessible information to recommendations in scientific articles from literature databases. Key findings: Analyzed articles suggest that impaired histamine degradation can result in multisystem symptoms, which may improve after implication dietary histamine restriction. The analysis of low-histamine diet recommendations revealed inconsistencies between internet-based information and literature from scientific databases. Conclusions: A low-histamine diet may provide clinical benefit in selected patients with histamine-related disorders. However, dietary recommendations are often inconsistent with scientific evidence. Implementation of the diet should be individualized and evidence-based. Further studies could be beneficial to establish clear and standardized dietary guidelines for histamine related conditions.
- Open Access
- 29 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50, 67961
β-Alanine Supplementation and Its Impact on Physical Performance: A Literature-Based Review
Purpose of research: This literature-based review synthesized the current evidence regarding the effects of β-alanine (BA) supplementation on human physical performance. The review focused on BA as the rate-limiting precursor for intramuscular carnosine synthesis and evaluated its ergogenic impact across various exercise modalities and durations. Research materials and methods: A structured literature search was conducted in major scientific databases, including PubMed, for English full-text articles available through 2025. Only Meta-Analyses, Systematic Reviews, and Randomized Controlled Trials were included, examining BA supplementation in human athletes or trained individuals compared with a placebo or control condition. Basic results: Chronic BA supplementation significantly increases muscle carnosine content and enhances intramuscular buffering capacity, delaying the onset of fatigue during high-intensity exercise. The most robust performance benefits are observed in efforts lasting approximately 1–4 minutes, with supplemental improvements noted in activities up to 10 minutes. BA also supports improvements in training volume and resistance to fatigue. Paresthesia remains the most commonly reported side effect. Conclusions:β-alanine is an evidence-based ergogenic aid that improves performance in high-intensity efforts requiring substantial buffering capacity. Chronic, divided dosing provides the greatest effectiveness.
- 29 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50, 67961
Open Accessβ-Alanine Supplementation and Its Impact on Physical Performance: A Literature-Based Review
Purpose of research: This literature-based review synthesized the current evidence regarding the effects of β-alanine (BA) supplementation on human physical performance. The review focused on BA as the rate-limiting precursor for intramuscular carnosine synthesis and evaluated its ergogenic impact across various exercise modalities and durations. Research materials and methods: A structured literature search was conducted in major scientific databases, including PubMed, for English full-text articles available through 2025. Only Meta-Analyses, Systematic Reviews, and Randomized Controlled Trials were included, examining BA supplementation in human athletes or trained individuals compared with a placebo or control condition. Basic results: Chronic BA supplementation significantly increases muscle carnosine content and enhances intramuscular buffering capacity, delaying the onset of fatigue during high-intensity exercise. The most robust performance benefits are observed in efforts lasting approximately 1–4 minutes, with supplemental improvements noted in activities up to 10 minutes. BA also supports improvements in training volume and resistance to fatigue. Paresthesia remains the most commonly reported side effect. Conclusions:β-alanine is an evidence-based ergogenic aid that improves performance in high-intensity efforts requiring substantial buffering capacity. Chronic, divided dosing provides the greatest effectiveness.
- Open Access
- 27 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Effectiveness of the Milwaukee Protocol in Human Rabies: A Review
Introduction Human rabies remains almost invariably fatal once clinical symptoms appear, despite widespread use of pre- and post-exposure prophylaxis. The so-called “Milwaukee Protocol” — a structured regimen of therapeutic coma, NMDA antagonists, antivirals and supportive care — generated intense interest after a single widely publicized survivor in 2004. Aim of the study This review summarizes current evidence on treatment of symptomatic human rabies with emphasis on the Milwaukee Protocol. Materials and Methods We synthesized published case reports, experimental studies, and review articles addressing therapies of clinical rabies and the Milwaukee Protocol. Key outcomes were survival, functional recovery, and reported adverse events. Limitations of the evidence base are highlighted. Results Documented recoveries prior to 2004 were rare but reported under intensive supportive care. The original Milwaukee Protocol case displayed substantial recovery and prompted iterative protocol versions. Subsequent application of the protocol worldwide has produced numerous reported failures; published, verifiable survivor accounts after 2004 remain scarce. Experimental data provide limited mechanistic support for core elements of the protocol. Mortality has not been convincingly reduced beyond outcomes achievable with modern intensive supportive care alone. Conclusions Current evidence does not conclusively support the Milwaukee Protocol as an effective, reproducible curative treatment for clinical rabies. High-quality clinical reporting and standardized case registries are needed before the protocol can be eventually recommended or totally abandoned. Meanwhile, prevention through vaccination of dogs and timely post-explosure prophylaxis remains the cornerstone of rabies control.
- 27 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Open AccessEffectiveness of the Milwaukee Protocol in Human Rabies: A Review
Introduction Human rabies remains almost invariably fatal once clinical symptoms appear, despite widespread use of pre- and post-exposure prophylaxis. The so-called “Milwaukee Protocol” — a structured regimen of therapeutic coma, NMDA antagonists, antivirals and supportive care — generated intense interest after a single widely publicized survivor in 2004. Aim of the study This review summarizes current evidence on treatment of symptomatic human rabies with emphasis on the Milwaukee Protocol. Materials and Methods We synthesized published case reports, experimental studies, and review articles addressing therapies of clinical rabies and the Milwaukee Protocol. Key outcomes were survival, functional recovery, and reported adverse events. Limitations of the evidence base are highlighted. Results Documented recoveries prior to 2004 were rare but reported under intensive supportive care. The original Milwaukee Protocol case displayed substantial recovery and prompted iterative protocol versions. Subsequent application of the protocol worldwide has produced numerous reported failures; published, verifiable survivor accounts after 2004 remain scarce. Experimental data provide limited mechanistic support for core elements of the protocol. Mortality has not been convincingly reduced beyond outcomes achievable with modern intensive supportive care alone. Conclusions Current evidence does not conclusively support the Milwaukee Protocol as an effective, reproducible curative treatment for clinical rabies. High-quality clinical reporting and standardized case registries are needed before the protocol can be eventually recommended or totally abandoned. Meanwhile, prevention through vaccination of dogs and timely post-explosure prophylaxis remains the cornerstone of rabies control.
- Open Access
- 2 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 48
Sensory Decline and Cardiovascular Risk in Older Adults: Psychosocial and Communication-Mediated Pathways – A narrative review
Background:Hearing loss affects roughly 65% of adults aged 70 and older, vision impairment 20–30%, and dual sensory loss becomes more common with age. Meta-analyses show that these forms of sensory decline are associated with higher risks of hypertension, stroke, coronary heart disease, and cardiovascular mortality, even after adjustment for traditional cardiovascular risk factors. Shared vascular pathology explains part of these associations, but psychosocial and communication pathways may also contribute. Aim:To summarize evidence on psychosocial and communication-mediated mechanisms linking sensory decline to cardiovascular risk in older adults and to outline an integrated conceptual model. Material and Methods:A narrative review was conducted using targeted searches of PubMed and Google Scholar. Meta-analyses, cohort studies, and relevant qualitative and mechanistic literature were included. Findings were synthesized qualitatively. Results:Sensory impairment increases cognitive and communicative demands, which may heighten chronic stress and influence neuroendocrine and inflammatory pathways linked to cardiovascular disease. Reduced sensory input limits social participation and contributes to social isolation and loneliness, both established cardiovascular risk factors. In healthcare settings, communication barriers can impair symptom reporting, treatment adherence, and management of complex cardiovascular regimens. These pathways complement biological mechanisms and help explain persistent associations between sensory decline and cardiovascular outcomes. Conclusions:Psychosocial and communication mechanisms appear to be modifiable contributors to cardiovascular vulnerability in older adults with sensory impairment. Potential strategies include routine sensory screening, communication-accessible care, and interventions addressing isolation and stress. Randomized trials are needed to determine whether sensory interventions can reduce cardiovascular events.
- 2 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 48
Open AccessSensory Decline and Cardiovascular Risk in Older Adults: Psychosocial and Communication-Mediated Pathways – A narrative review
Background:Hearing loss affects roughly 65% of adults aged 70 and older, vision impairment 20–30%, and dual sensory loss becomes more common with age. Meta-analyses show that these forms of sensory decline are associated with higher risks of hypertension, stroke, coronary heart disease, and cardiovascular mortality, even after adjustment for traditional cardiovascular risk factors. Shared vascular pathology explains part of these associations, but psychosocial and communication pathways may also contribute. Aim:To summarize evidence on psychosocial and communication-mediated mechanisms linking sensory decline to cardiovascular risk in older adults and to outline an integrated conceptual model. Material and Methods:A narrative review was conducted using targeted searches of PubMed and Google Scholar. Meta-analyses, cohort studies, and relevant qualitative and mechanistic literature were included. Findings were synthesized qualitatively. Results:Sensory impairment increases cognitive and communicative demands, which may heighten chronic stress and influence neuroendocrine and inflammatory pathways linked to cardiovascular disease. Reduced sensory input limits social participation and contributes to social isolation and loneliness, both established cardiovascular risk factors. In healthcare settings, communication barriers can impair symptom reporting, treatment adherence, and management of complex cardiovascular regimens. These pathways complement biological mechanisms and help explain persistent associations between sensory decline and cardiovascular outcomes. Conclusions:Psychosocial and communication mechanisms appear to be modifiable contributors to cardiovascular vulnerability in older adults with sensory impairment. Potential strategies include routine sensory screening, communication-accessible care, and interventions addressing isolation and stress. Randomized trials are needed to determine whether sensory interventions can reduce cardiovascular events.